Serum Vascular Endothelial Growth Factor and Serum Leptin in Patients with Cervical Cancer
- 1 April 2002
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 85 (1) , 32-35
- https://doi.org/10.1006/gyno.2001.6517
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Vascular endothelial growth factor and prognosis of cervical carcinomaObstetrics & Gynecology, 2000
- Vascular endothelial growth factor (VEGF) expression is a prognostic factor for radiotherapy outcome in advanced carcinoma of the cervixBritish Journal of Cancer, 2000
- Vascular endothelial growth factor in cervical carcinomaPublished by Wolters Kluwer Health ,1999
- Vascular endothelial growth factor is implicated in early invasion in cervical cancerEuropean Journal Of Cancer, 1999
- Complete Remission of Metastatic Cervical Cancer with the Angiogenesis Inhibitor TNP-470New England Journal of Medicine, 1998
- Correlation of Vascular Endothelial Growth Factor Expression and Microvessel Density in Cervical Intraepithelial NeoplasiaJNCI Journal of the National Cancer Institute, 1997
- Biological properties of VEGF/VPF receptorsCancer and Metastasis Reviews, 1996
- Vascular Permeability Factor (Vascular Endothelial Growth Factor) Expression and Angiogenesis in Cervical NeoplasiaJNCI Journal of the National Cancer Institute, 1995
- Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospectsJournal of Molecular Medicine, 1995
- Angiogenesis in cancer, vascular, rheumatoid and other diseaseNature Medicine, 1995